EU Clinical Trial Update:
On-Demand Webinar

Home / Clinical Services /

Understanding the changes and impact of the EU Clinical Trial Regulation

European Union Clinical Trial Regulation 536/2014 (EU CTR) became applicable on January 31, 2022 and has introduced a more centralised approach to clinical trial conduct in the EU, enhanced transparency requirements, and a new GMP framework for Investigational Medicinal Products (IMPs).

Almac Clinical Services is ready to support delivery of your investigational products as you navigate the transition from Directive 2001/20/EC to Regulation 536/2014 and will continue to support the delivery of investigational products in the EU and beyond.

Please complete the form to gain access to the Webinar.

This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies